KR vs RAPT · P/E 19, rev $147.12B vs $132.1M cap
Kroger Company (KR) versus RAPT Therapeutics Inc (RAPT) — a side-by-side from cached financials, not a winner call.
Kroger Company (KR) is a grocery stores company listed on US.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Latest reported KR revenue for 2025-02-01 was $147.12B. Net income was $2.67B. KR currently screens at market cap $46.17B and trailing P/E 19.0.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
KR currently screens at market cap $46.17B and trailing P/E 19.0. RAPT currently screens at market cap $132.1M.
Not investment advice. Open the KR and RAPT stock pages for the full models.
Not investment advice.